As researchers and manufacturers develop and produce vaccines to protect against COVID-19 and other infectious agents, it is critical to demonstrate the vaccines’ quality, safety, and efficacy. In less than two years since the start of the devastating global pandemic caused by coronavirus SARS-CoV-2, scientists have developed over 300 candidate vaccines, and some received approval in less than a year. Significant advances in multiple manufacturing platforms and analytical technologies support the rapid pace of vaccine development. Some of the new COVID-19 vaccines have spurred the use of novel analytical technologies to support rapid and thorough characterization, which may help pave the way for other vaccine manufacturers to implement these technologies. Now more than ever, it is vital to develop and improve tests and analytical methods that ensure the quality of vaccines and maintain public trust.

Subject area:
Biologics

Objectives (If applicable):
NA

Target Audience (If applicable):
QA Manager
QA Staff
QC Chemist
QC Manager
R&D
Regulatory
Student